Transduction of human embryonic stem cells by foamy virus vectors

Molecular Therapy

Volumn 15, Issue 10, 2007, Pages 1827-1833

  Gharwan, Helen ^a   Hirata, Roli K ^a   Wang, Peirong ^a   Richard, Robert E ^a   Wang, Linlin ^a   Olson, Erik ^a   Allen, James ^a   Ware, Carol B ^b   Russell, David W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETROVIRUS VECTOR; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA INTEGRATION; DNA MODIFICATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROVIRUS; RHESUS MONKEY; SOUTHERN BLOTTING; SPUMA VIRUS; TERATOMA; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS VIRULENCE;

HUMAN SPUMARETROVIRUS; MACACA MULATTA;

EID: 34548735287     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300244     Document Type: Article

References (46)

1. Thomson, JA, Itskovitz-Eldor, J, Shapiro, SS, Waknitz, MA, Swiergiel, JJ, Marshall, VS et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
2. Urbach, A, Schuldiner, M and Benvenisty, N (2004). Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells. Stem Cells 22: 635-641.
3. Eiges, R, Schuldiner, M, Drukker, M, Yanuka, O, Itskovitz-Eldor, J and Benvenisty, N (2001). Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol 11: 514-518.
4. Gerrard, L, Zhao, D, Clark, AJ and Cui, W (2005). Stably transfected human embryonic stem cell clones express OCT4-specific green fluorescent protein and maintain self-renewal and pluripotency. Stem Cells 23: 124-133.
5. Vallier, L, Rugg-Gunn, PJ, Bouhon, IA, Andersson, FK, Sadler, AJ and Pedersen, RA (2004). Enhancing and diminishing gene function in human embryonic stem cells. Stem Cells 22: 2-11.
6. Zwaka, TP and Thomson, JA (2003). Homologous recombination in human embryonic stem cells. Not Biotechnol 21: 319-321.
7. Pfeifer, A, Ikawa, M, Dayn, Y and Verma, IM (2002). Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci USA 99 2140-2145.
8. Gropp, M, Itsykson, P, Singer, O, Ben-Hur, T, Reinhartz, E, Galun, E et al. (2003). Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol Ther 7: 281-287.
9. Ma, Y, Ramezani, A, Lewis, R, Hawley, RG and Thomson, JA (2003). High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 21: 111-117.
10. Ben-Dor, I, Itsykson, P, Goldenberg, D, Galun, E and Reubinoff, BE (2006). Lentiviral vectors harboring a dual-gene system allow high and homogeneous transgene expression in selected polyclonal human embryonic stem cells. Mol Ther 14: 255-267.
11. Smith-Arica, JR, Thomson, AJ, Ansell, R, Chlorini, J, Davidson, B and McWhir, J (2003). Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors. Cloning Stem Cells 5: 51-62.
12. Schweizer, M, Turek, R, Hahn, H, Schliephake, A, Netzer, KO, Eder, G et al. (1995). Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses 11: 161-170.
13. Rethwilm, A, Erlwein, O, Baunach, G, Maurer, B and ter Meulen, V (1991). The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci USA 88: 941-945.
14. Yu, SF, Baldwin, DN, Gwynn, SR, Yendapalli, S and Linial, ML (1996). Human foamy virus replication: A pathway distinct from that of retroviruses and hepadnaviruses. Science 271: 1579-1582.
15. Erwein, O, Bieniasz, PD and McClure, MO (1998). Sequences in pol are required for transfer of human foamy virus-based vectors. J Virol 72: 5510-5516.
16. Heinkelein, M, Schmidt M, Fischer, N, Moebes, A, Lindemann, D, Enssle, J et al. (1998). Characterization of a cis-acting sequence in the pol region required to transfer human foamy virus vectors. J Virol 72: 6307-6314.
17. Falcone, V, Schweizer, M and Neumann-Haefelin, D (2003). Replication of primate foamy viruses in natural and experimental hosts. Curr Top Microbiol Immunol 277: 161-180.
18. Heneine, W, Schweizer, M, Sandstrom, P and Folks, T (2003). Human infection with foamy viruses. Curr Top Microbiol Immunol 277 181-196.
19. Trobridge, G, Josephson, N, Vassilopoulos, G, Mac, J and Russell, DW (2002). Improved foamy virus vectors with minimal viral sequences. Mol Ther 6: 321-328.
20. Russell, DW and Miller, AD (1996). Foamy virus vectors. J Virol 70: 217-222.
21. Trobridge, G and Russell, DW (2004). Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol 78: 2327-2335.
22. Hill, CL, Bieniasz, PD and McClure, MO (1999). Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol 80: 2003-2009.
23. Trobridge, GD, Miller, DG, Jacobs, MA, Allen, JM, Kiem, HP, Kaul, R et al. (2006). Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci USA 103: 1498-1503.
24. Vassilopoulos, G, Trobridge, G, Josephson, NC and Russell, DW (2001). Gene transfer into murine hematopoietic stem cells with helper-free foamy virus vectors. Blood 98: 604-609.
25. Josephson, NC, Vassilopoulos, G, Trobridge, GD, Priestley, GV, Wood, BL, Papayannopoulou, T et al. (2002). Transduction of human NOD/ SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc Natl Acad Sci USA 99: 8295-8300.
26. + cord blood cells. Hum Gene Ther 14 509-519.
27. + NOD/ SCID-repopulating cells by simian foamy virus type 1 (SFV-1) vector. Virology 302: 229-235.
28. Trobridge, G, Vassilopoulos, G, Josephson, N and Russell, DW.(2002). Gene transfer with foamy virus vectors. Methods Enzymol 346: 628-648.
29. Brivanlou, AH, Gage, FH, Jaenisch, R, Jessell, T, Melton, D and Rossant, J (2003). Stem cells. Setting standards for human embryonic stem cells. Science 300: 913-916.
30. Chambers, I, Colby, D, Robertson, M, Nichols, J, Lee, S, Tweedie, S et al. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
31. Schuldiner, M, Yanuka, O, Itskovitz-Eldor, J, Melton, DA and Benvenisty, N (2000). Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 97: 11307-11312.
32. Ware, CB, Nelson, AM and Blau, CA (2006). A comparison of NIH-approved human ESC lines. Stem Cells 24: 2677-2684.
33. Asano, T, Hanazono, Y, Ueda, Y, Muramatsu, S, Kume, A, Suemori, H et al. (2002). Highly efficient gene transfer into primate embryonic stem cells with a simian. lentivirus vector. Mol Ther 6: 162-168.
34. Besnier, C, Takeuchi, Y and Towers, G (2002). Restriction of lentivirus in monkeys. Proc Natl Acad Sci USA 99: 11920-11925.
35. Cowan, S, Hatziioannou, T, Cunningham, T, Muesing, MA, Gottlinger, HG and Bieniasz, PD (2002). Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci USA 99: 11914-11919.
36. Hanawa, H, Hematti, P, Keyvanfar, K, Metzger, ME, Krouse, A, Donahue, RE et al. (2004). Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 103: 4062-4069.
37. Logan, AC, Haas, DL, Kafri, T and Kohn, DB (2004). Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J Virol 78: 8421-8436.
38. Abeyta, MJ, Clark, AT, Rodriguez, RT, Bodnar, MS, Pera, RA and Firpo, MT (2004). Unique gene expression signatures of independently-derived human embryonic stem cell lines. Hum Mol Genet 13: 601-608.
39. Brimble, SN, Zeng, X, Weiler, DA, Luo, Y, Liu, Y, Lyons, IG et al. (2004). Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13 585-597.
40. Thomson, JA, Kalishman, J, Golos, TG, Duming, M, Harris, CP, Becker, RA et al (1995). Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA 92: 7844-7848.
41. Tucker, KL, Wang, Y, Dausman, J and Jaenisch, R (1997). A transgenic mouse strain expressing four drug-selectable marker genes. Nucleic Acids Res 25: 3745-3746.
42. Ware, CB, Nelson, AM and Blau, CA (2005). Controlled-rate freezing of human ES cells. Biotechniques 38: 879-880, 882-873.
43. Xu, C, Inokuma, MS, Denham, J, Golds, K, Kundu, P, Gold, JD et al. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19: 971-974.
44. Henderson, JK, Draper, JS, Baillie, HS, Fishel, S, Thomson, JA, Moore, H et al. (2002). Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20: 329-337.
45. Pickering, SJ, Braude, PR, Patel, M, Burns, CJ, Trussler, J. Bolton, V et al. (2003). Preimplantation genetic diagnosis as a novel source of embryos for stem cell research. Reprod Biomed Online 7: 353-364.
46. Richards, M, Tan, SP, Tan, JH, Chan, WK and Bongso, A (2004). The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22: 51-64.